Skip to main content

Table 4 Univariate and multivariate analysis of postoperative severe complications

From: Serum GP73 predicts posthepatectomy outcomes in patients with hepatocellular carcinoma

Variables No complications Complications Univariate analysis Multivariate analysis
251 29 P OR (95% CI) P
Gender 217/34 21/8 0.045   
Age (year) (≤ 50 vs > 50) 117/134 14/15 0.865   
Diabetes (yes vs no) 19/232 3/26 0.486   
Hypertension (yes vs no) 46/205 7/22 0.449   
ASA grading (≤ 2 vs > 2) 178/73 17/12 0.173   
Total bilirubin (μmol/L) 20.6 ± 33.5 57.6 ± 97.3 0.052   
Albumin (g/L) 39.4 ± 5.6 36.9 ± 4.1 0.021   
ALT (U/L) 48.8 ± 42.8 100.6 ± 116.6 0.024 1.006 (1.001–1.011) 0.019
AST (U/L) 51.1 ± 52.7 106.2 ± 110.6 0.013   
GP73 (≤ 79.2 vs > 79.2 ng/mL) 151/100 5/24 < 0.001 4.970 (1.654–14.934) 0.004
Size of tumor (cm) 6.1 ± 3.5 7.3 ± 4.5 0.065   
Number of tumors 1.2 ± 0.5 1.1 ± 0.4 0.785   
Operation time (min) 230.0 ± 208.7 263.8 ± 98.6 0.390   
Blood loss (mL) 705.3 ± 789.9 1669.0 ± 1662.6 0.004 1.001 (1.000–1.001) < 0.001
Intraoperative RBC transfusion 2.5 ± 2.9 6.0 ± 6.5 < 0.001   
  1. AST aspartate aminotransferase, ALT alanine aminotransferase, ASA American Society of Anesthesiology, RBC red blood cell